ArticleMicrobial cell factories2024
Management of a ciprofloxacin as a contaminant of emerging concern in water using microalgaebioremediation: mechanism, modeling, and kinetic studies.
Article in Microbial cell factories, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Performance evaluation of a polydopamine-modified carbon cloth bioanode for concurrent bioelectricity generation and ciprofloxacin transformation within a microbial fuel cell.Bioprocess and biosystems engineering · 2026Article
- Different Strains of Microalgae in a Microbial Consortium Remove Antibiotics from Urban Wastewater in Batch and Continuous Treatment Systems.ACS omega · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmaceutical residues, now recognized as a new category of environmental pollutants, have potentially risks to both ecosystems and human health effects. Recently, biosorption has emerged as one of the most promising strategies for managing these pharmaceutical wastes in water. Nevertheless, the environmental impact of the adsorbents presents a challenge to the advancement of this process. Therefore, the present study proposed two biosorbent: Chlorella vulgaris and Synechocystis sp. microalgae to manage Ciprofloxacin (CIP) in water. The experimental findings revealed that the optimal conditions for adsorption conditions are CIP initial concentration 4.0 mg/L and pH 5 and 3 for Synechocystissp. and C. vulgaris, respectively. The adsorption process followed the Pseudo-second-order kinetic model. The main mechanism of biosorption is the complexation of CIP with carboxyl, hydroxyl, carbonyl, and amido groups which was confirmed by Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and energy-dispersive X-ray spectrometry (EDX) analyses. These analyses confirmed the presence of CIP on the surface of tested microalgal cells. These results indicated that the adsorption mechanism of CIP by Synechocystis sp. PCC6803 and C. vulgaris offers theoretical insights into the biosorption mechanisms of pharmaceutical residues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.